Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
McKesson
Harvard Business School
AstraZeneca
Cipla
Baxter
Johnson and Johnson
McKinsey
Queensland Health

Generated: December 12, 2018

DrugPatentWatch Database Preview

Formulation information for generic ingredient: tolvaptan

« Back to Dashboard

Tolvaptan

CASRN: 150683-30-0UNII:

Manufacturing Methods

<truncated in preview>

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Medtronic
AstraZeneca
Citi
Harvard Business School
Julphar
Daiichi Sankyo
Federal Trade Commission
Dow